» Articles » PMID: 39408166

ICardioMonitor Digital Monitoring System for People with Heart Failure: Development and Evaluation of Its Accessibility and Usability

Overview
Specialty Health Services
Date 2024 Oct 16
PMID 39408166
Authors
Affiliations
Soon will be listed here.
Abstract

The use of eHealth as a monitoring system in people with heart failure (HF) has been shown to be effective in promoting self-care and reducing re-admissions and mortality. The present study develops and evaluates the accessibility and usability of the web app iCardioMonitor HF monitoring system. This study consisted of two stages. The first stage (co-design) comprised two phases: (1) analysis of the scientific literature and expert opinions and (2) co-design of the iCardioMonitor (web app plus a knowledge-base algorithm) and definition of alert criteria. The second stage (cross-sectional descriptive study) analyzed system accessibility (% of people using the iCardioMonitor and % of parameters recorded) and usability, employing the Spanish version of the System Usability Scale for the Assessment of Electronic Tools. The iCardioMonitor was configured by a web app and an algorithm with the capacity to detect decompensated HF automatically. A total of 45 patients with an average age of 55.8 years (standard deviation [SD] = 10.582) and an average time since diagnosis of 7.1 years (SD = 7.471) participated in the second stage. The percentage of iCardioMonitor use was 83.2%. The average usability score was 77.2 points (SD = 21.828), higher in women than men (89.2; SD = 1.443-76.0; SD = 1.443) ( = 0.004). The usability score was higher the shorter the time since diagnosis (r = 0.402; = 0.025) and the higher the number of responses (r = 0.377; = 0.031). The results obtained show that iCardioMonitor is a tool accepted by patients and has obtained a remarkable score on the usability scale. iCardioMonitor was configured by a web app and an algorithm with the capacity to detect decompensated HF automatically.

References
1.
McDonagh T, Metra M, Adamo M, Gardner R, Baumbach A, Bohm M . Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With.... Eur Heart J. 2021; 42(48):4901. DOI: 10.1093/eurheartj/ehab670. View

2.
Sicras-Mainar A, Sicras-Navarro A, Palacios B, Varela L, Delgado J . Epidemiology and treatment of heart failure in Spain: the HF-PATHWAYS study. Rev Esp Cardiol (Engl Ed). 2020; 75(1):31-38. DOI: 10.1016/j.rec.2020.09.033. View

3.
. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1789-1858. PMC: 6227754. DOI: 10.1016/S0140-6736(18)32279-7. View

4.
Allemann H, Andreasson F, Hanson E, Magnusson L, Jaarsma T, Thylen I . The co-design of an online support programme with and for informal carers of people with heart failure: A methodological paper. J Clin Nurs. 2023; 32(19-20):7589-7604. DOI: 10.1111/jocn.16856. View

5.
Nick J, Roberts L, Petersen A . Effectiveness of telemonitoring on self-care behaviors among community-dwelling adults with heart failure: a quantitative systematic review. JBI Evid Synth. 2021; 19(10):2659-2694. PMC: 8528136. DOI: 10.11124/JBIES-20-00329. View